Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial
BACKGROUND Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) compromise physical activity and quality of life and contribute significantly to health care costs. Systemic glucocorticoids benefit clinical outcome in AECOPD, and the REDUCE trial demonstrated noninferiori...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2017-05-01
|
| سلاسل: | Swiss Medical Weekly |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.smw.ch/index.php/smw/article/view/2304 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|